Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis

Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis. Guerrini-Rousseau, L.; Dufour, C.; Varlet, P.; Masliah-Planchon, J.; Bourdeaut, F.; Guillaud-Bataille, M.; Abbas, R.; Bertozzi, A. I.; Fouyssac, F.; Huybrechts, S.; Puget, S.; Bressac-De Paillerets, B.; Caron, O.; Sevenet, N.; Dimaria, M.; Villebasse, S.; Delattre, O.; Valteau-Couanet, D.; Grill, J.; Brugières, L.. Neuro Oncol. 2018; 1122-1132: p.1122-1132. doi:10.1093/neuonc/nox228
Article